Virtual Meeting to be held on July 9 hosted by B. Riley.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUVB:
- Nuvation Bio’s Strategic Positioning and Financial Strength Justify Buy Rating
- Nuvation Bio announces taletrectinib as preferred agent in NCCN Guidelines
- Nuvation Bio price target lowered to $6 from $10 at RBC Capital
- Buy Rating for Nuvation Bio’s IBTROZI: FDA Approval and Competitive Edge in ROS1+ NSCLC Treatment
- Nuvation Bio’s IBTROZI Receives FDA Approval